Impact of Hospital Case Volume on Uterine Sarcoma Prognosis: SARCUT Study Subanalysis

CONCLUSIONS: The prognosis for patients with uterine sarcoma is directly related to complete tumor cytoreduction, histologic type, and FIGO stage, with significant differences between low and high case-volume centers. Patients with uterine sarcomas should be centralized in HighCV centers to improve their oncologic outcomes.PMID:37460742 | DOI:10.1245/s10434-023-13826-4

Source: Ann Oncol - July 17, 2023 Category: Cancer & Oncology Authors: Mikel Gorostidi Yusuf Yildirim Ronalds Macuks Rosanna Mancari Patriciu Achimas-Cadariu Eduardo Iba ñez Giacomo Corrado Arnoldas Bartusevicius Olena Sukhina Ignacio Zapardiel SARCUT Study Group Source Type: research